Laeremans T, Janssens A, Aerts J
Immunotherapy. 2025; 17(2):133-145.
PMID: 39905963
PMC: 11901454.
DOI: 10.1080/1750743X.2025.2460965.
Alles M, Demberg T, Liyanage N
Curr Opin HIV AIDS. 2025; 20(2):145-153.
PMID: 39774039
PMC: 11802316.
DOI: 10.1097/COH.0000000000000913.
Naidoo K, Altfeld M
Viruses. 2024; 16(10).
PMID: 39459918
PMC: 11512232.
DOI: 10.3390/v16101584.
Batohi N, Shalekoff S, Shalekoff S, Martinson N, Ebrahim O, Tiemessen C
J Acquir Immune Defic Syndr. 2024; 97(5):522-532.
PMID: 39219024
PMC: 11540281.
DOI: 10.1097/QAI.0000000000003518.
Kuan C, Yang I, Chang C, Chen Z, Lin J, Kuo W
APL Bioeng. 2024; 8(3):036107.
PMID: 39131207
PMC: 11315581.
DOI: 10.1063/5.0198191.
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.
Anderko R, DePuyt A, Bronson R, Bullotta A, Aga E, Bosch R
J Immunol. 2024; 212(10):1564-1578.
PMID: 38551350
PMC: 11073922.
DOI: 10.4049/jimmunol.2300672.
Early elevated IFNα is a key mediator of HIV pathogenesis.
Le Buanec H, Schiavon V, Merandet M, How-Kit A, Bergerat D, Fombellida-Lopez C
Commun Med (Lond). 2024; 4(1):53.
PMID: 38504106
PMC: 10951235.
DOI: 10.1038/s43856-024-00454-6.
Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications.
Letafati A, Salahi Ardekani O, Naderisemiromi M, Norouzi M, Shafiei M, Nik S
Virol J. 2024; 21(1):18.
PMID: 38216935
PMC: 10785350.
DOI: 10.1186/s12985-024-02287-0.
Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure.
Schober R, Brandus B, Laeremans T, Iserentant G, Rolin C, Dessilly G
J Transl Med. 2023; 21(1):791.
PMID: 37936122
PMC: 10631209.
DOI: 10.1186/s12967-023-04669-4.
OMIP-098: A 26 parameter, 24 color flow cytometry panel for human memory NK cell phenotyping.
Creegan M, Degler J, Paquin-Proulx D, Eller M, Machmach K
Cytometry A. 2023; 103(12):941-946.
PMID: 37807668
PMC: 10872854.
DOI: 10.1002/cyto.a.24802.
Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism.
Sugawara S, Hueber B, Woolley G, Terry K, Kroll K, Manickam C
PLoS Pathog. 2023; 19(9):e1011629.
PMID: 37669308
PMC: 10503717.
DOI: 10.1371/journal.ppat.1011629.
Gestational Viral Infections: Role of Host Immune System.
Beltrami S, Rizzo S, Schiuma G, Speltri G, Di Luca D, Rizzo R
Microorganisms. 2023; 11(7).
PMID: 37512810
PMC: 10383666.
DOI: 10.3390/microorganisms11071637.
Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
Moyano A, Ndlovu B, Mbele M, Naidoo K, Khan N, Mann J
PLoS One. 2023; 18(6):e0286507.
PMID: 37267224
PMC: 10237385.
DOI: 10.1371/journal.pone.0286507.
CD3CD56 and CD3CD56 lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and C.
de Almeida S, Beltrame M, Tang B, Rotta I, Justus J, Schluga Y
J Neuroimmunol. 2023; 377:578067.
PMID: 36965365
PMC: 10817703.
DOI: 10.1016/j.jneuroim.2023.578067.
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality.
Laeremans T, den Roover S, Lungu C, Dhaese S, Gruters R, Allard S
NPJ Vaccines. 2023; 8(1):29.
PMID: 36864042
PMC: 9980861.
DOI: 10.1038/s41541-023-00631-z.
Mapping the interplay between NK cells and HIV: therapeutic implications.
Anderko R, Mailliard R
J Leukoc Biol. 2023; 113(2):109-138.
PMID: 36822173
PMC: 10043732.
DOI: 10.1093/jleuko/qiac007.
Mucosal-homing natural killer cells are associated with aging in persons living with HIV.
Kroll K, Shah S, Lucar O, Premeaux T, Shikuma C, Corley M
Cell Rep Med. 2022; 3(10):100773.
PMID: 36208628
PMC: 9589002.
DOI: 10.1016/j.xcrm.2022.100773.
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.
Pace M, Ogbe A, Hurst J, Robinson N, Meyerowitz J, Olejniczak N
Front Immunol. 2022; 13:878743.
PMID: 36110857
PMC: 9468877.
DOI: 10.3389/fimmu.2022.878743.
Elevated KIR expression and diminished intensity of CD7 on NK cell subsets among treatment naïve HIV infected Ethiopians.
Andualem H, Lemma M, Keflie A, Workeneh M, Ayelign B, Tassachew Y
Sci Rep. 2022; 12(1):14747.
PMID: 36042218
PMC: 9427747.
DOI: 10.1038/s41598-022-18413-3.
Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir.
Choudhary M, Cyktor J, Riddler S
J Virus Erad. 2022; 8(2):100073.
PMID: 35784676
PMC: 9241028.
DOI: 10.1016/j.jve.2022.100073.